Company intelligence / Profile preview

ZAS Corporation

Dhaka, Bangladesh

Ownership: Private
Employees: ~100
Development stage: Other

Overview

ZAS specializes in the import and export of rare, niche, and lifesaving medicines (including generics, biosimilars, and orphan drugs), serving critical care (ICU/NICU/PICU) and multiple specialty indications, with a reputation for quality and compliance in Bangladesh and international markets.

Therapeutic areas: Metabolic DisordersOphthalmologyRare DiseasesHematologyOtherOncologyNeurologyWomen's Health
Modalities: Small moleculeBiologicBiosimilar
Industry: Non-Academic Healthcare

Partnerships

Over 100 global partners for import/export; specifics are not disclosed

Beyond the preview

Go deeper on ZAS Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZAS Corporation.

Explore the full profile